202 related articles for article (PubMed ID: 1978710)
41. Signaling requirements for the expression of the transactivating factor NF-AT in human T lymphocytes.
Hivroz-Burgaud C; Clipstone NA; Cantrell DA
Eur J Immunol; 1991 Nov; 21(11):2811-9. PubMed ID: 1682154
[TBL] [Abstract][Full Text] [Related]
42. Mechanisms of immune memory. T cell activation and CD3 phosphorylation correlates with Ta1 (CDw26) expression.
Hafler DA; Chofflon M; Benjamin D; Dang NH; Breitmeyer J
J Immunol; 1989 Apr; 142(8):2590-6. PubMed ID: 2564857
[TBL] [Abstract][Full Text] [Related]
43. CD2 can mediate TCR/CD3-independent T cell activation.
Ohno H; Ushiyama C; Taniguchi M; Germain RN; Saito T
J Immunol; 1991 Jun; 146(11):3742-6. PubMed ID: 1674520
[TBL] [Abstract][Full Text] [Related]
44. Human CD2 is functional in CD2 transgenic mice.
Monostori E; Lang G; Kioussis D; Cantrell DA; Zamoyska R; Brown MH; Crumpton MJ
Immunology; 1991 Nov; 74(3):369-72. PubMed ID: 1685144
[TBL] [Abstract][Full Text] [Related]
45. Regulation of tumor necrosis factor (TNF)-alpha synthesis and TNF receptors expression in T lymphocytes through the CD2 activation pathway.
Santis AG; Campanero MR; Alonso JL; Sánchez-Madrid F
Eur J Immunol; 1992 Dec; 22(12):3155-60. PubMed ID: 1359970
[TBL] [Abstract][Full Text] [Related]
46. An anti-CD2 monoclonal antibody that both inhibits and stimulates T cell activation recognizes a subregion of CD2 distinct from known ligand-binding sites.
Kozarsky KF; Tsai C; Bott CM; Allada G; Li LL; Fox DA
Cell Immunol; 1993 Sep; 150(2):235-46. PubMed ID: 8103706
[TBL] [Abstract][Full Text] [Related]
47. T-T cell interactions are mediated by adhesion molecules.
Brod SA; Purvee M; Benjamin D; Hafler DA
Eur J Immunol; 1990 Oct; 20(10):2259-68. PubMed ID: 1700751
[TBL] [Abstract][Full Text] [Related]
48. Stimulation through the TCR/CD3 complex up-regulates the CD2 surface expression on human T lymphocytes.
Alberola-Ila J; Places L; de la Calle O; Romero M; Yagüe J; Gallart T; Vives J; Lozano F
J Immunol; 1991 Feb; 146(4):1085-92. PubMed ID: 1671400
[TBL] [Abstract][Full Text] [Related]
49. Immunodeficiency with low expression of the T cell receptor/CD3 complex. Effect on T lymphocyte activation.
Le Deist F; Thoenes G; Corado J; Lisowska-Grospierre B; Fischer A
Eur J Immunol; 1991 Jul; 21(7):1641-7. PubMed ID: 1676369
[TBL] [Abstract][Full Text] [Related]
50. Antigen-specific T cell unresponsiveness in cloned helper T cells mediated via the CD2 or CD3/Ti receptor pathways.
Lamb JR; Zanders ED; Sewell W; Crumpton MJ; Feldmann M; Owen MJ
Eur J Immunol; 1987 Nov; 17(11):1641-4. PubMed ID: 2960547
[TBL] [Abstract][Full Text] [Related]
51. Immunoregulatory functions of paf-acether. II. Decrease of CD2 and CD3 antigen expression.
Vivier E; Salem P; Dulioust A; Praseuth D; Metezeau P; Benveniste J; Thomas Y
Eur J Immunol; 1988 Mar; 18(3):425-30. PubMed ID: 2895712
[TBL] [Abstract][Full Text] [Related]
52. Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation.
Carabasi MH; DiSanto JP; Yang SY; Dupont B
Tissue Antigens; 1991 Jan; 37(1):26-32. PubMed ID: 1676547
[TBL] [Abstract][Full Text] [Related]
53. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
Suthanthiran M
J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176
[TBL] [Abstract][Full Text] [Related]
54. Association of CD2 and CD45 on human T lymphocytes.
Schraven B; Samstag Y; Altevogt P; Meuer SC
Nature; 1990 May; 345(6270):71-4. PubMed ID: 1970422
[TBL] [Abstract][Full Text] [Related]
55. Inhibitory effects of anti-CD2 monoclonal antibodies on interleukin 2 production and interleukin 2 receptor expression in anti-CD3-induced T cell activation.
Stohl W; Linker-Israeli M
Cell Immunol; 1989 May; 120(2):351-65. PubMed ID: 2566387
[TBL] [Abstract][Full Text] [Related]
56. Stimulation of CD2-negative T cells by staphylococcal enterotoxin superantigens.
Duan XC; Kabelitz D
Immunol Lett; 1991 Aug; 29(3):219-22. PubMed ID: 1685147
[TBL] [Abstract][Full Text] [Related]
57. Peripheral T-lymphocyte activation by human T-cell leukemia virus type I interferes with the CD2 but not with the CD3/TCR pathway.
Dodon MD; Bernard A; Gazzolo L
J Virol; 1989 Dec; 63(12):5413-9. PubMed ID: 2573739
[TBL] [Abstract][Full Text] [Related]
58. Interdependence of CD3-Ti and CD2 activation pathways in human T lymphocytes.
Alcover A; Alberini C; Acuto O; Clayton LK; Transy C; Spagnoli GC; Moingeon P; Lopez P; Reinherz EL
EMBO J; 1988 Jul; 7(7):1973-7. PubMed ID: 2901344
[TBL] [Abstract][Full Text] [Related]
59. Activation of MAP-2 kinase activity by the CD2 receptor in Jurkat T cells can be reversed by CD45 phosphatase.
Nel AE; Ledbetter JA; Williams K; Ho P; Akerley B; Franklin K; Katz R
Immunology; 1991 Jun; 73(2):129-33. PubMed ID: 1676984
[TBL] [Abstract][Full Text] [Related]
60. Continuous in vivo activation and transient hyporesponsiveness to TcR/CD3 triggering of human gut lamina propria lymphocytes.
De Maria R; Fais S; Silvestri M; Frati L; Pallone F; Santoni A; Testi R
Eur J Immunol; 1993 Dec; 23(12):3104-8. PubMed ID: 8258323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
